Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000494:pharmacology*; D001786:Blood Glucose / Q000032:analysis; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism; D010455:Peptides / Q000009:adverse effects / Q000494:pharmacology*
D001786:Blood Glucose; D007328:Insulin; D010455:Peptides; D013006:Growth Hormone; D005934:Glucagon; D001120:Arginine